Phase II study of doxorubicin and cisplatin in patients with metastatic hepatocellular carcinoma

被引:0
|
作者
Jeeyun Lee
Joon Oh Park
Won Seog Kim
Se Hoon Park
Keon Woo Park
Moon Seok Choi
Joon Hyoek Lee
Kwang Cheol Koh
Seung Woon Paik
Byung Chul Yoo
Jaewon Joh
Kihyun Kim
Chul Won Jung
Young Suk Park
Young-Hyuck Im
Won Ki Kang
Mark H. Lee
Keunchil Park
机构
[1] Sungkyunkwan University School of Medicine,Division of Hematology/Oncology, Department of Medicine, Samsung Medical Center
[2] Sungkyunkwan University School of Medicine,Division of Gastroenterology, Department of Medicine, Samsung Medical Center
[3] Sungkyunkwan University School of Medicine,Department of Surgery, Samsung Medical Center
来源
Cancer Chemotherapy and Pharmacology | 2004年 / 54卷
关键词
Doxorubicin; Cisplatin; Hepatocellular carcinoma;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:385 / 390
页数:5
相关论文
共 50 条
  • [41] Phase II study of darinaparsin in patients with advanced hepatocellular carcinoma
    Jennifer Wu
    Charles Henderson
    Lynn Feun
    Peter Van Veldhuizen
    Philip Gold
    Hui Zheng
    Theresa Ryan
    Lawrence S. Blaszkowsky
    HaoBin Chen
    Max Costa
    Barry Rosenzweig
    MaryLynn Nierodzik
    Howard Hochster
    Franco Muggia
    Giovanni Abbadessa
    Jonathan Lewis
    Andrew X. Zhu
    Investigational New Drugs, 2010, 28 : 670 - 676
  • [42] Phase II study of hepatic arterial infusion of a fine-powder formulation of cisplatin for advanced hepatocellular carcinoma
    Yoshikawa, Masaharu
    Ono, Naofumi
    Yodono, Hiraku
    Ichida, Takafumi
    Nakamura, Hironobu
    HEPATOLOGY RESEARCH, 2008, 38 (05) : 474 - 483
  • [43] Phase II study of gemcitabine in patients with advanced hepatocellular carcinoma
    Yang, TS
    Lin, YC
    Chen, JS
    Wang, HM
    Wang, CH
    CANCER, 2000, 89 (04) : 750 - 756
  • [44] Induction with mitomycin C, doxorubicin, cisplatin and maintenance with weekly 5-fluorouracil, leucovorin for treatment of metastatic nasopharyngeal carcinoma: a phase II study
    R L Hong
    T S Sheen
    J Y Ko
    M M Hsu
    C C Wang
    L L Ting
    British Journal of Cancer, 1999, 80 : 1962 - 1967
  • [45] Induction with mitomycin C, doxorubicin, cisplatin and maintenance with weekly 5-fluorouracil, leucovorin for treatment of metastatic nasopharyngeal carcinoma: a phase II study
    Hong, RL
    Sheen, TS
    Ko, JY
    Hsu, MM
    Wang, CC
    Ting, LL
    BRITISH JOURNAL OF CANCER, 1999, 80 (12) : 1962 - 1967
  • [46] Treatment of inoperable hepatocellular carcinoma with pegylated liposomal doxorubicin (PLD): results of a phase II study
    J W Valle
    A Dangoor
    J Beech
    D J Sherlock
    S M Lee
    J H Scarffe
    R Swindell
    M Ranson
    British Journal of Cancer, 2005, 92 : 628 - 630
  • [47] Treatment of inoperable hepatocellular carcinoma with pegylated liposomal doxorubicin (PLD): results of a phase II study
    Valle, JW
    Dangoor, A
    Beech, J
    Sherlock, DJ
    Lee, SM
    Scarffe, JH
    Swindell, R
    Ranson, M
    BRITISH JOURNAL OF CANCER, 2005, 92 (04) : 628 - 630
  • [48] Phase II study of combination doxorubicin, interferon-α, and high-dose tamoxifen treatment for advanced hepatocellular carcinoma
    Lu, YS
    Hsu, CU
    Li, CC
    Kuo, SH
    Yeh, KH
    Yang, CH
    Hsu, CH
    Wu, CY
    Cheng, AL
    HEPATO-GASTROENTEROLOGY, 2004, 51 (57) : 815 - 819
  • [49] Phase II study of capecitabine and cisplatin combination as first-line chemotherapy in Chinese patients with metastatic nasopharyngeal carcinoma
    Yu-Hong Li
    Feng-Hua Wang
    Wen-Qi Jiang
    Xiao-Juan Xiang
    Yan-Ming Deng
    Guo-Qing Hu
    De-Ming Xu
    Yan Chen
    Qing Lin
    You-Jian He
    Cancer Chemotherapy and Pharmacology, 2008, 62 : 539 - 544
  • [50] A phase II study of combination chemotherapy with capecitabine and cisplatin in patients with metastatic or recurrent squamous cell carcinoma of the head and neck
    Won, Y. -W.
    Park, Y. H.
    Ahn, M. J.
    Do, I. -G.
    Ko, Y. H.
    Park, K.
    ANNALS OF ONCOLOGY, 2011, 22 (02) : 417 - 423